Background: Exacerbations of COPD can range from those that are nuisances to those that are life threatening, but treatment can shorten the duration of illness and improve outcomes.

So this study intended to find out the mortality rate in patients with COPD acute exacerbations and also to find out simple clinical and laboratory parameters that may predict the mortality in these patients and also influence of BODE Index on the treatment outcome of COPD exacerbations.

Objective: To find out the influence of BODE index in the treatment outcome of COPD during acute exacerbation.

Materials and Methods: This study was an observational study. All cases of COPD diagnosed by a physician and on treatment for more than one year, admitted in Institute of Chest Diseases with exacerbation were included in the study. BODE Index was calculated.

Data were collected and tabulated. Statistical analysis was done using SPSS Software version 12.0 and Epi Info version 3.4.1

Results: This study gives a brief idea about the mortality rate in COPD acute exacerbations.. All the patients were males. 34 patients died during treatment. In the study, most of the patients belong to the age group between 60 – 70 years. BODE score >7 was found to be a predictor of mortality in these patients by univariate analysis (p value =0.036).But there was no statistical significance with multivariate analysis for this observation.

Conclusion: Mortality rate of COPD acute exacerbations was 33.66% in this observational study. BODE score >7 was found to be a predictor of mortality in COPD acute exacerbations by univariate analysis.

1. Global Strategy For Diagnosis, Management, And Prevention Of Chronic Obstructive Pulmonary Disease, 2019
2. ATS/ERS Summary: Standards for the diagnosis and treatment of patients with COPD

3. Fishman’s Pulmonary Diseases and Disorders Fourth Edition p 691- 931
4. Predictors of hospital outcome and intubation in COPD patients admitted to respiratory icu for acute hypercapnic respiratory failure Ucqun l, Metintas M, Moral H, Alatas F, Yildrim H, Erqinel S; Department of chest diseases medical faculty Osmangazi university, Tr 26040 Eskisehir Turkey; Respir Med 2006 Jan,100(1);66-74
5. Divay Chandra, Kalpalatha K. Guntupalli and Randeep Guleria Departments of Internal Medicine and Pulmonary Medicine, All India Institute of Medical Sciences, New Delhi, India and Department of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas, USA ;Indian J Chest Dis Allied Sci 2007; 49: 13-18
6. In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease Susheel P. Patil, MD; Jerry A. Krishnan, MD; Noah Lechtzin, MD, MHS; Gregory B. Diette, MD, MHS; Arch Intern Med. 2003;163:1180-1186.
7. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy ; Marti, X. Muñoz, J. Rios, F.Morell and J.Ferrer Servei de Pneumologia, Hospital General Vall d'Hebron, and Laboratori de Bioestadística i Epidemiologia, Universtitat Autònoma de Barcelona, Barcelona, Spain; Eur Respir J 2006; 27:689-696.
8. Management of Acute Exacerbations of COPD A Summary and Appraisal of Published Evidence; Douglas C. McCrory, MD, MHSc, Cynthia Brown, MD, Sarah E. Gelfand, BA, and Peter B. Bach, MD CHEST April 2001 vol. 119 no. 4 1190-1209
9. R..Celli, M.D and et al; Body Mass Index, Airflow Obstruction, Dysnoea and Exercise capacity Index in Chronic Obstructive Pulmonary Diseases; The NEJM Volume 350:1005 - 1012, March 4 2004.
10. Predictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction; Fernando J Martinez^*, Gregory Foster, Jeffrey L Curtis, Gerard Criner^. Gail Weinmann, Alfred Fishman, Malcolm M DeCamp, Joshua Benditt, Frank Sciurba, Barry Make, Zab Mohsenifar¹

Dr Durga Balagopalan

Assistant Professor Malabar Medical College Kozhikode